AUSTRALIAN REGULATORY AFFAIRS · CLINICAL DEVELOPMENT · MARKET ENTRY

Navigate Australian Regulatory Strategy with Confidence

Director-led regulatory strategy, clinical development and Australian market-entry support for pharmaceutical, biotechnology, medical technology and other life-sciences organisations — from early development and clinical trials through to TGA registration and lifecycle management.

Discuss Your Australian Strategy

Director-led Australian regulatory expertise across the product lifecycle

Tricode Clinical provides specialist Australian regulatory, clinical development and Local Sponsor support to pharmaceutical, biotechnology, medical technology and other life-sciences organisations. We combine senior regulatory advice with practical execution, helping clients navigate Australian requirements and progress programmes with greater clarity and confidence.

About Tricode Clinical

Tricode Clinical is a specialist Australian regulatory consultancy supporting pharmaceutical, biotechnology, medical technology and other life-sciences organisations across clinical development, regulatory strategy, marketing authorisation and product lifecycle activities.

We provide senior, Director-led Australian regulatory support for local and international programmes.

Director-led expertise

Tricode Clinical is led by Peter Lynch, Founder and Director, who brings more than 25 years of regulatory affairs experience. His background includes working within the Therapeutic Goods Administration and serving as Country Head of Regulatory Affairs for Australia and New Zealand at a major global CRO, supporting multi-jurisdictional programmes across APAC, Europe and North America.

Peter has acted as a key interface with the TGA, Medsafe and the Office of the Gene Technology Regulator across clinical trial and marketing authorisation programmes. His experience spans CTN and CTA pathways, marketing authorisation strategy, advanced therapies, gene technology and product lifecycle management.

Clients work directly with the Director throughout the engagement. There are no layered account teams or unnecessary organisational handovers.

Regulatory support across the Australian product lifecycle

Australian Regulatory Strategy

  • Australian development and market-entry planning
  • TGA pathway and submission strategy
  • Regulatory gap assessment
  • International reliance and work-sharing considerations
  • Regulatory sequencing and programme planning
  • Regulatory planning informed by market-access and commercial objectives

Clinical Trial Regulatory Support

Director-led Australian regulatory support for CTN and CTA pathway planning, HREC coordination and study start-up, working alongside sponsor, CRO and site teams.

  • CTN and CTA pathway strategy
  • HREC and Australian start-up coordination
  • Overseas sponsor and Local Sponsor interface
View Clinical Trial Support

TGA Marketing Authorisations

  • Pre-submission strategy
  • Prescription medicine registration support
  • Orphan Drug Designation
  • Priority Review and relevant evaluation pathways
  • TGA liaison and response management

OGTR and Advanced Therapies

  • OGTR pathway assessment
  • DNIR and DIR applications
  • Institutional Biosafety Committee coordination
  • Gene therapy and GMO clinical trial support
  • Parallel coordination of OGTR and HREC requirements

Local Sponsor and Regulatory Agent

  • Flexible Local Sponsor arrangements
  • Regulatory Agent support
  • Australian regulatory representation
  • Governance and compliance oversight
  • Clear responsibilities and accountability

Lifecycle Management

  • Variations and notifications
  • Renewals
  • Post-approval regulatory activities
  • Product information support
  • Ongoing Australian regulatory advice

When clients engage Tricode Clinical

Clients engage Tricode when they need senior Australian regulatory judgement, ownership of a defined workstream or an appropriate Australian regulatory presence.

Entering Australia for the first time

For organisations adding Australia to a global development or commercialisation programme and needing clarity on local pathways, sequencing and responsibilities.

Needing senior Australian regulatory judgement

For programmes where pathway selection, Australian interpretation or TGA-facing decisions require experienced local expertise.

Requiring ownership of a defined workstream

For sponsors that need a senior Australian regulatory partner to lead a specific activity or interface, including trial start-up, alongside existing programme structures.

Requiring Australian regulatory presence

For organisations needing Local Sponsor or Regulatory Agent support with clearly defined responsibilities and accountability.

Ways to engage

Senior strategic adviceRegulatory judgement, pathway strategy, review and advisory support.

Defined regulatory executionOwnership and delivery of agreed Australian regulatory workstreams.

Australian regulatory presenceLocal Sponsor or Regulatory Agent responsibilities where appropriate.

Why Tricode Clinical

Director-led regulatory involvement

Clients work directly with the Director across both regulatory strategy and delivery.

Australian market focus

Advice grounded in Australian regulatory requirements and their practical application to global development programmes.

Integrated strategic perspective

Regulatory decisions considered alongside clinical development, international sequencing, market-entry and lifecycle objectives.

Engagement built around the programme

Tricode can provide senior regulatory advice, lead defined Australian workstreams or integrate with internal teams, CROs and other providers where specialist Australian expertise is required.

Melbourne skyline at night

Why Australia?

Australia can play a valuable role in global development and commercialisation programmes, supported by a high-quality clinical research environment and an established regulatory framework.

Clinical development environment

Experienced investigators, high-quality research infrastructure and internationally recognised capabilities support early and later-stage clinical development.

Established regulatory framework

TGA pathways and established ethics and governance processes provide a defined environment for Australian clinical and regulatory activities.

Strategic global and Asia-Pacific role

Australian activities can form part of broader international development, registration and commercialisation planning across global and regional programmes.

Regulatory Insights and Resources

Cover of Tricode Clinical’s Strategic Guide to Australian Market Entry
STRATEGIC REGULATORY GUIDE

Strategic Guide to Australian Market Entry

Regulatory and market-access insights for organisations evaluating Australian pathways, clinical development opportunities and the interaction between registration, reimbursement and commercial planning.

Download the Report

TGA Clinical Trial Submission Checklist

A practical checklist covering CTN vs CTA pathways, required documents, HREC requirements, and common pitfalls to avoid.

Access the Guide

OGTR Gene Therapy Quick Guide

Key requirements for clinical trials involving GMOs, including DNIR vs DIR pathways, IBC processes, and common pitfalls.

Access the Guide

Local Sponsor vs Regulatory Agent Matrix

Clear comparison of the different models available to meet Australia’s Local Sponsor requirements, including pros and considerations.

Access the Guide

Discuss Your Australian Regulatory Strategy

Tell us about your programme, regulatory priorities or planned Australian activities. Tricode Clinical will review your enquiry and contact you to arrange an initial discussion.

Please do not include confidential or patient-identifiable information. We can arrange an appropriate confidentiality agreement before discussing sensitive programme details.

Your information will be handled in accordance with our Privacy Policy.

Prefer email? You can also contact Tricode Clinical at info@tricodeclinical.com.au.